References
- Salinas S, Proukakis C, Crosby A, Warner TT. Hereditary Spastic Paraplegia: a clinical and pathogenetic approach. Lancet Neurology. 2008;12:1127–38.
- Schule R, Schlipf N, Synofzik M, Klebe S, Klimpe S, Hehr U, . Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry. 2009;80;1402–4.
- Stevanin G, Azzedine H, Denora, Boukhris A, Tazir M, Lossos A, . Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor degeneration. Brain. 2008; 131:772–84.
- Wilkinson PA, Crosby AH, Turner C, Bradley J, Ginsberg L, Wood NW, . A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain. 2004;127:973–80.
- Simons P, Al-Shawi R, Minogue S, Waugh MG, Wiedemann C, Evangelou S, . Loss of phosphatidylinositol 4-kinase 2-α activity causes late onset degeneration of spinal cord axons. Pro Natl Acad Sci. 2009;106;11535–9.
- Ribai P, Stevanin G, Bouslam N, Pontier B, Nelson I, Fontaine B, . A new phenotype linked to SPG27 and refinement of the critical region on chromosome 10. J Neurol. 2006;253:714–9.